兴齐眼药
(300573)
| 流通市值：101.12亿 | | | 总市值：131.67亿 |
| 流通股本：2.74亿 | | | 总股本：3.57亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 683,337,441.58 | 2,472,852,236.79 | 1,903,728,804.18 | 1,162,742,877.58 |
| 营业收入 | 683,337,441.58 | 2,472,852,236.79 | 1,903,728,804.18 | 1,162,742,877.58 |
| 二、营业总成本 | 456,989,442.88 | 1,667,470,697.01 | 1,215,800,734.13 | 779,972,185.27 |
| 营业成本 | 122,644,319.06 | 465,962,118.19 | 355,470,544.74 | 224,704,634.68 |
| 税金及附加 | 9,244,272.6 | 32,831,651.69 | 26,879,833.5 | 16,274,403.57 |
| 销售费用 | 199,598,174.58 | 763,972,611.16 | 555,474,170.54 | 366,101,237.17 |
| 管理费用 | 41,752,758.11 | 174,547,138.04 | 118,939,414.98 | 77,895,153.89 |
| 研发费用 | 84,474,178.33 | 225,910,095.09 | 155,124,563.1 | 91,760,465.26 |
| 财务费用 | -724,259.8 | 4,247,082.84 | 3,912,207.27 | 3,236,290.7 |
| 其中:利息费用 | 481,320.49 | 4,435,786.8 | 3,804,566.19 | 2,803,405.09 |
| 其中:利息收入 | 408,353.82 | 2,252,622.99 | 1,853,220.02 | 1,390,970.39 |
| 三、其他经营收益 | | | | |
| 资产处置收益 | - | 52,536.38 | 74,560.73 | 74,796.81 |
| 资产减值损失(新) | -30,626.73 | -15,176,291.68 | -7,765,922.42 | -7,641,667.71 |
| 信用减值损失(新) | -526,819.54 | -2,174,108.55 | -4,776,248.77 | -1,148,966.11 |
| 其他收益 | 6,787,149.17 | 34,138,553.38 | 28,007,361.32 | 21,740,080.8 |
| 四、营业利润 | 232,577,701.6 | 822,222,229.31 | 703,467,820.91 | 395,794,936.1 |
| 加:营业外收入 | 10,000 | 517,251.63 | 183,758 | 83,758 |
| 减:营业外支出 | 2,468,274.91 | 22,463,807.22 | 14,880,706.36 | 11,172,467.98 |
| 五、利润总额 | 230,119,426.69 | 800,275,673.72 | 688,770,872.55 | 384,706,226.12 |
| 减:所得税费用 | 23,705,152.2 | 104,420,077.47 | 89,864,486.4 | 49,880,171.32 |
| 六、净利润 | 206,414,274.49 | 695,855,596.25 | 598,906,386.15 | 334,826,054.8 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 206,414,274.49 | 695,855,596.25 | 598,906,386.15 | 334,826,054.8 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 206,414,274.49 | 695,855,596.25 | 598,906,386.15 | 334,826,054.8 |
| 扣除非经常损益后的净利润 | 206,363,102.71 | 697,046,957.34 | 596,091,025.14 | 330,984,652.17 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.84 | 2.83 | 2.44 | 1.36 |
| (二)稀释每股收益 | 0.84 | 2.83 | 2.44 | 1.36 |
| 八、其他综合收益 | - | 1,416,666.67 | - | - |
| 归属于母公司股东的其他综合收益 | - | 1,416,666.67 | - | - |
| 九、综合收益总额 | 206,414,274.49 | 697,272,262.92 | 598,906,386.15 | 334,826,054.8 |
| 归属于母公司股东的综合收益总额 | 206,414,274.49 | 697,272,262.92 | 598,906,386.15 | 334,826,054.8 |
| 公告日期 | 2026-04-28 | 2026-04-22 | 2025-10-29 | 2025-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |